Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sight Sciences, Inc. - Common Stock (NQ:SGHT)

9.760 +0.080 (+0.83%)
Delayed Quote Updated: 4:00 PM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Sight Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Sight Sciences (SGHT) Q3 2026 Earnings Call Transcript ↗
Dry eye sales climbed sharply and full-year guidance moved higher. 
Via The Motley Fool
Topics Earnings
News headline image
What Sight Sciences (SGHT) Said on Its Q3 Earnings Call ↗
Sight Sciences (NASDAQ:SGHT) raised its full-year revenue outlook after reporting record third-quarter sales, driven by growth in its glaucoma business and increased adoption of its TearCare dry eye... 
Via MarketBeat
Topics Earnings
Sight Sciences (NASDAQ:SGHT) Screens Strong on Minervini Trend Template and High-Growth Momentum ↗
Via Chartmill
News headline image
Sight Sciences (SGHT) Q2 2026 Earnings Call Transcript ↗
Dry eye adoption scaled while glaucoma gained major insurance coverage. 
Via The Motley Fool
Topics Earnings Intellectual Property World Trade
Sight Sciences (NASDAQ:SGHT) Beats Q2 Estimates and Raises Guidance, but Shares Dip ↗
Via Chartmill
Sight Sciences Inc (NASDAQ:SGHT) Reports Mixed Q4 2025 Results, Beats on EPS but Misses Revenue ↗
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Sight Sciences Q2 Earnings Call Highlights ↗
Sight Sciences (NASDAQ:SGHT) reported second-quarter revenue growth of 20% year over year, supported by gains in its interventional glaucoma and interventional dry eye businesses, while reducing... 
Via MarketBeat
Topics Earnings
News headline image
Sight Sciences (SGHT) Q1 2026 Earnings Transcript ↗
Sight Sciences (SGHT) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
Keep an eye on the top gainers and losers in Thursday's session. ↗
Via Chartmill
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
Breaking Down Sight Sciences: 6 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Sight Sciences ↗
 
Via Benzinga
News headline image
Expert Outlook: Sight Sciences Through The Eyes Of 5 Analysts ↗
 
Via Benzinga
Which stocks are experiencing notable movement on Thursday? ↗
Via Chartmill
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Sight Sciences (SGHT) Q4 2025 Earnings Transcript ↗
Sight Sciences (SGHT) Q4 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Sight Sciences (SGHT) Q3 2025 Earnings Transcript ↗
Sight Sciences (SGHT) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property World Trade
News headline image
Where Sight Sciences Stands With Analysts ↗
 
Via Benzinga
News headline image
Top movers in Friday's session ↗
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Top stock movements in today's session. ↗
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Which stocks are gapping on Friday? ↗
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
News headline image
UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures ↗
UnitedHealthcare's new policy covers implant-free glaucoma surgeries like OMNI, supporting treatment for mild to moderate open-angle glaucoma and cataracts. 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Sight Sciences ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Sight Sciences In The Eyes Of 4 Experts ↗
 
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
Wondering what's happening in Monday's pre-market session? Find an overview in this article. 
Via Chartmill
News headline image
These stocks are moving in today's pre-market session ↗
The US market session of Wednesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
Earnings Scheduled For March 5, 2025 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.